Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Midazolam for ROP Screening Pain
NCT06889376Phase 1Not yet recruiting
- Sponsor
- Instytut Centrum Zdrowia Matki Polki
- Start
- Mar 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of midazolam in procedural pain (2 arms), sponsored by Instytut Centrum Zdrowia Matki Polki. Primary endpoint: Premature Infant Pain Profile. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
midazolam
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06889376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06889376.